Small Pilot Study Indicates Qualia Life May Increase NAD+

Neurohacker Collective, nutritional supplement company announces the preliminary results of pilot study measuring blood levels of NAD+ while taking Qualia Life

News provided by

Neurohacker Collective

Jan 12, 2021, 06:00 ET

CARLSBAD, Calif., Jan. 12, 2021 /PRNewswire/ -- Neurohacker Collective announced the preliminary results of a small pilot study done in collaboration with Longevity Diagnostics Research on its healthy aging supplement Qualia Life. The results suggest that Qualia Life may enhance NAD⁺ in humans.

Qualia Life was orally administered for 4 weeks to 9 healthy adults. NAD⁺ levels increased by 85% after 5 days and by 100% (p = 0.0555) after 4 weeks of taking Qualia Life. Other molecules in the NAD metabolome, including NMN and NADH, also increased substantially after 4 weeks.

Qualia Life was specifically designed to combat the aging process by comprehensively supporting mitochondrial fitness, NAD⁺, AMPK, ATP, insulin signalling and several other biological processes. Boosting NAD⁺ levels is just one aspect of the product.

Gregory Kelly, ND, Director of Product Development at Neurohacker Collective, commented, "NAD⁺ levels decline with aging. These initial findings suggest that Qualia Life may be able to increase NAD⁺ levels in people of a variety of ages, and may contribute to healthy aging. These results support Neurohacker Collective's complex systems science approach to enhancing NAD⁺ and related molecules."

Shawn Ramer, PhD, Chief Scientific Officer at Neurohacker Collective commented, "While a larger placebo controlled study will be required to confirm the findings, the results of this pilot study are indeed encouraging."

"While the results we saw from taking Qualia Life are exciting, we engaged in this study also to advance the science of NAD⁺ measurement. Testing for NAD⁺ and its metabolites is not commercially available, which is surprising given the emerging research on NAD's importance in healthy aging. Our hope is that the research being done by Longevity Diagnostics Research will lead to NAD⁺ testing becoming widespread and accessible." Neurohacker CEO, James Schmachtenberger.

About Neurohacker Collective
Neurohacker Collective was founded in 2015 with the mission to advance human quality of life by creating best in class well-being products. Neurohacker Collective's products are radically different because they employ a unique methodology to research and development based on complex systems science. This scientific approach focuses on supporting the body's ability to self-regulate. The company began with a focus on cognitive products with the launch of Qualia Mind and has since developed products to support longevity, energy, sleep and immunity. Learn more about their scientific approach here.

Background on Qualia Life
Qualia Life is a synergistic blend of nutrients that support healthy aging. It was developed to support NAD⁺, ATP, mitochondrial performance, and cellular energy production. To find more information about Qualia Life visit https://neurohacker.com/shop/qualia-life

About Longevity Diagnostics Research
Longevity Diagnostics Research was founded to advance the science of NAD testing. The company is currently involved in obtaining information on the effectiveness of different collection and preparation methods for measuring NAD biomarkers. For more information visit https://nadtest.com/.

SOURCE Neurohacker Collective